AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Using index funds to manage risk emphasizes broad diversification and low costs. These funds help smooth returns and reduce exposure to idiosyncratic losses.
27,240 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Tech-led optimism lifts the Nasdaq Composite as oil prices retreat. Traders weigh the Fed path and AI earnings signal...
Adobe stock is staging a comeback after a brutal selloff, with stronger earnings and AI-driven growth fueling optimis...
Binance is stepping up talks with European regulators to win a MiCA license, aiming to keep services flowing across t...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
A year of explosive AI-driven demand has propelled Micron to the forefront of memory chips. Now investors wonder if t...
U.S. stocks rose as markets entered a holiday-shortened week ahead of the Fourth of July. The S&P 500 led gains while...
As Alphabet grapples with a recent stock slump, analysts argue the dip may present a tactical buying opportunity amid...
CoreWeave unleashed resilient US-scale growth with a massive backlog, while Nebius posted stronger margins on a small...
Nvidia faces a temporary pullback as AI names retreat, but long‑term demand for data‑center GPUs and AI infrastructur...
Tesla is signaling a profitability-focused future with autonomy and robotics, while BYD drives volume with affordable...
Prediction markets are painting a different picture from AI headlines, placing Anthropic ahead of OpenAI for a 2026 l...